Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 2292 | 344 | 0.0934 | 0.0857 | 0.1501 | 0.1490 |
A-375 | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 1336 | 436 | 0.0431 | 0.0435 | 0.3263 | 0.3296 |
A-375 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 2887 | 241 | 0.1268 | 0.1293 | 0.0835 | 0.0864 |
A-375 | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 2479 | 317 | 0.1036 | 0.1027 | 0.1279 | 0.1177 |
A-375 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 2192 | 327 | 0.0894 | 0.0857 | 0.1492 | 0.1490 |
A-375 | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1574 | 486 | 0.0521 | 0.0435 | 0.3088 | 0.3296 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 947 | 180 | 0.0388 | 0.0433 | 0.1901 | 0.1874 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 914 | 160 | 0.0382 | 0.0434 | 0.1751 | 0.1958 |
A-375 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 3008 | 255 | 0.1319 | 0.1293 | 0.0848 | 0.0864 |
A-375 | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 2487 | 272 | 0.1062 | 0.1027 | 0.1094 | 0.1177 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 1138 | 197 | 0.0477 | 0.0492 | 0.1731 | 0.1635 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 1025 | 203 | 0.0416 | 0.0434 | 0.1980 | 0.1958 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1196 | 197 | 0.0506 | 0.0492 | 0.1647 | 0.1635 |
A-375 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 1822 | 269 | 0.0744 | 0.0857 | 0.1476 | 0.1490 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 3477 | 209 | 0.1655 | 0.1621 | 0.0601 | 0.0672 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 3598 | 270 | 0.1685 | 0.1621 | 0.0750 | 0.0672 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 3221 | 214 | 0.1523 | 0.1621 | 0.0664 | 0.0672 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 1153 | 176 | 0.0495 | 0.0492 | 0.1526 | 0.1635 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 1189 | 229 | 0.0486 | 0.0433 | 0.1926 | 0.1874 |
A-375 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 2966 | 270 | 0.1292 | 0.1293 | 0.0910 | 0.0864 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 1025 | 184 | 0.0426 | 0.0433 | 0.1795 | 0.1874 |
A-375 | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 2320 | 269 | 0.0983 | 0.1027 | 0.1159 | 0.1177 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1265 | 271 | 0.0503 | 0.0434 | 0.2142 | 0.1958 |
A-375 | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 1 | 2723 | 183 | 0.1598 | 0.1658 | 0.0672 | 0.0732 |
A-375 | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 1142 | 404 | 0.0354 | 0.0435 | 0.3538 | 0.3296 |